CDEK
← All drugs Report issue

ly3819253

mAbexperimental

Clinical trial activity

14 trials · 29 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
8
Phase 3
5
Phase 4
2

Earliest trial started May 28, 2020 (NCT04411628)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • SARS-CoV-2Immunity, passive

    SARS-CoV-2 immunity, passive

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04796402Phase 4Mar 17, 2021BC Academic Health Science Network, Fraser Health, Government of British Columbia, University of British Columbia, University of London
NCT04790786Phase 3Mar 10, 2021Berry Consultants, University of Pittsburgh
NCT04701658Phase 2Feb 1, 2021AbCellera Biologics Inc., Eli Lilly
NCT04656691Phase 4Dec 31, 2020Eli Lilly, Optum, ProHEALTH Care Associates, LLP, UnitedHealth Group
NCT04840459Phase 2Nov 20, 2020DHR Health Institute for Research and Development, DHR Heath Institute for Research and Development
NCT04634409Phase 2Oct 29, 2020AbCellera Biologics Inc., Eli Lilly, Shanghai Junshi Bioscience Co.,Ltd.
NCT04537910Phase 1Sep 2, 2020Eli Lilly
NCT04518410Phase 2/Phase 3 (Phase 3)Aug 19, 2020AIDS Clinical Trials Group, Eli Lilly, National Institute of Allergy and Infectious Diseases (NIAID), University of California, San Diego
NCT05780268Phase 3Aug 5, 2020AIDS Clinical Trials Group, Cardiothoracic Surgical Trials Network, Department of Veteran Affairs, Eli Lilly, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), Medical Research Council, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), University of Copenhagen, University of Minnesota, University of New South Wales
NCT04501978Phase 3Aug 4, 2020Brii Biosciences, Department of Veteran Affairs, Eli Lilly, GlaxoSmithKline, International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), Medical Research Council, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Allergy and Infectious Diseases (NIAID), University of Copenhagen, University of Minnesota, University of New South Wales, Vir Biotechnology, Inc.
NCT04497987Phase 3Aug 2, 2020AbCellera Biologics Inc., Eli Lilly, National Institute of Allergy and Infectious Diseases (NIAID), Shanghai Junshi Bioscience Co.,Ltd.
NCT04427501Phase 2Jun 13, 2020AbCellera Biologics Inc., Eli Lilly
NCT04411628Phase 1May 28, 2020AbCellera Biologics Inc., Eli Lilly
NCT04603651N/A—AbCellera Biologics Inc., Eli Lilly
Showing 14 of 14 trials
Page 1 / 1

Organizations

Research & Development (29)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Eli LillyFor profit11752020
AbCellera Biologics Inc.For profit6042020
National Institute of Allergy and Infectious Diseases (NIAID)Government4312020
AIDS Clinical Trials GroupAcademic/Hospital2012020
Department of Veteran AffairsGovernment2012020
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)Academic/Hospital2012020
Medical Research CouncilGovernment2012020
National Heart, Lung, and Blood Institute (NHLBI)Government2012020
Shanghai Junshi Bioscience Co.,Ltd.For profit2022020
University of CopenhagenAcademic/Hospital2012020
University of MinnesotaAcademic/Hospital2012020
University of New South WalesAcademic/Hospital2012020
BC Academic Health Science NetworkAcademic/Hospital1012021
Berry ConsultantsFor profit1012021
Brii BiosciencesFor profit1012020
Cardiothoracic Surgical Trials NetworkAcademic/Hospital1012020
DHR Health Institute for Research and DevelopmentAcademic/Hospital1112020
DHR Heath Institute for Research and DevelopmentAcademic/Hospital1012020
Fraser HealthAcademic/Hospital1112021
GlaxoSmithKlineFor profit1012020
29 organizations
Page 1 / 2